Subsidy under-recovery in Q4
Management noted that DAP margins are not adequate due to raw material cost increases; representation to government ongoing, but correction may not happen before April.
medium · management_commentaryCoromandel reported a stellar Q3 FY25 with consolidated revenue of INR 7,049 crore (+28% YoY) and EBITDA of INR 722 crore (+102% YoY), driven by record NPK volumes (11.4 lakh to...
Financial stats pending filing verification
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Management noted that DAP margins are not adequate due to raw material cost increases; representation to government ongoing, but correction may not happen before April.
medium · management_commentarySudden spike in sulfur and sulfuric acid prices due to demand from China and Indonesia could impact input costs.
medium · management_commentaryExport volumes in bioproducts were impacted due to delays in order finalization, though expected to recover in Q4.
low · management_commentaryAnalyst raised concern about pricing-led competition in export markets; management acknowledged but highlighted diversification and formulation foray as mitigants.
medium · analyst_question